Friday, 12 August 2016

GLENMARK PHARMA Q1



Consol Net Profit Up 28%  At  RS 227 Cr Vs 183 Cr YoY

 Consol Revenue At RS 1,943 Cr  Vs RS 1,626 Cr YoY

 India Business up 10.39% 

 US Business up 24.44% 

 Europe Formulations Business up 36.5%⁠⁠⁠⁠
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)